Johnson & Johnson wins U.S. FDA approval for bladder cancer drug
Johnson & Johnson's drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday.
from Reuters: Health News https://reut.rs/2v3HQn3
http://bit.ly/2zwRqiM